Atossa Therapeutics, Inc. (ATOS)
NASDAQ · Manufacturing · Pharmaceutical preparations
$2.65−$0.1300 (−4.68%) on the dayAs of the close; data may be delayed.
ATOS price, last 12 months
Key stats
- Previous close
- $2.78
- Open
- $2.78
- Day range
- $2.53 – $3.12
- 52-week range
- $1.70 – $16.50
- Volume
- 227K
- Avg volume (20 days)
- 99.7K
- Market cap
- $24.3M
Performance
1W+5.0%
1M+6.8%
3M+2.9%
6M−56.0%
YTD−71.0%
1Y−83.7%
vs S&P 500, 1Y−99.7 pts
Technicals and fundamentals
About Atossa Therapeutics, Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $24.3M